TAURX ADVANCED THERAPEUTICS LIMITED

🌿Early-stageactive
SC711914 · ltd · incorporated 2021-10-11
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
🔒Estimated value
Upgrade to see
Turnover
year to Oct 2024
Net worth
book net assets
Opportunity
70/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
Pursue
Strong opportunity: active trading company with strong profile and acceptable with review structure.

Opportunity 70/100 (strong), bankability 70/100. Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (58/100).

Data confidence

Overall: high (82/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (2 active, 2 linked, 2 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
11 connected companies via shared directors
78
Filing history
13 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
70/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
60
Adequate — check latest filings for context.
Acquirability
50
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
Current Assets
Current Liabilities
£0£0£0£0£0£0Oct 2023Oct 2024

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2024-10-312023-10-31

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

Recent activity

Last 30 days
0
filings
Last 90 days
0
filings
Last 180 days
0
filings
Counts from Companies House filing history.
Corporate timeline (12 events)Click to expand
  1. 2025-07-10
    📄
    change-person-director-company-with-change-date
    officers · CH01
  2. 2025-07-07
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  3. 2025-02-24
    📄
    change-person-director-company-with-change-date
    officers · CH01
  4. 2024-07-23
    CORR, Glenn Andrew appointed
    director
  5. 2024-07-23
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  6. 2024-07-23
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  7. 2023-04-03
    📄
    accounts-with-accounts-type-dormant
    accounts · AA
  8. 2022-11-21
    📄
    memorandum-articles
    incorporation · MA
  9. 2022-11-21
    📄
    resolution
    resolution · RESOLUTIONS
  10. 2021-10-11
    🏢
    Company incorporated
    As TAURX ADVANCED THERAPEUTICS LIMITED
  11. 2021-10-11
    SCHEMBRI-WISCHIK, Marcus appointed
    director
  12. 2021-10-11
    📄
    incorporation-company
    incorporation · NEWINC

Owner dependency

58/100
Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.

Succession & seller-readiness

36/100
Weak signal

Limited succession signal. Not a near-term off-market candidate.

SIGNALS
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Group structure

Taurx Therapeutics Management Ltd. is the ultimate parent — holding 75%+ shares. This company sits inside their group.

🏛️
Taurx Therapeutics Management Ltd.
Corporate parent · holds 75-100% shares · board control
ultimate parent
TAURX ADVANCED THERAPEUTICS LIMITED
This company · SC711914

Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Taurx Therapeutics Management Ltd.
Corporate entity
75100%
75–100%board control75-100% shares · 75-100% voting · board control11/10/2021

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Professional services · AB postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
STREAMLINE SHIPPING GROUP LIMITED
SC131956 · est 1991
£15.91M
£11.73M£20.10M
035y8374y
GENERAL OCEANS UK HOLDINGS LTD
SC308386 · est 2006
£9.77M
£7.20M£12.34M
019y8468y
HIGHLAND FUELS HOLDINGS LIMITED
SC215790 · est 2001
£9.50M
£7.00M£12.00M
30025y8862y
CRAIGSHANNOCH LIMITED
SC191743 · est 1998
£5.90M
£4.34M£7.45M
£2.95M30027y8867y
HSB HOLDINGS LIMITED
SC260511 · est 2003
£3.58M
£2.64M£4.52M
022y8461y
T D C PARSONS PEEBLES LIMITED
SC663297 · est 2020
£2.76M
£2.03M£3.48M
£11.52M51005y8777y
ROTECH HOLDINGS LIMITED
SC148822 · est 1994
£1.97M
£1.45M£2.49M
£453.6k032y9258y
WELLTEC (UK) LTD.
SC204742 · est 2000
£134.9k
£99.4k£170.4k
£17.23M320026y8562y
ACCURA MEASUREMENT LIMITED
SC322109 · est 2007
£5.47M19y8360y
ALLEN ASSOCIATES (H.P.E.) LIMITED
SC201596 · est 1999 · no financials extracted
26y8359y
BOURTREE INVESTMENTS LIMITED
SC190868 · est 1998
27y8361y
CONNECT NDT LIMITED
SC205224 · est 2000
26y8370y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2021-10-11
Jurisdictionscotland
Primary SIC72110 — Research and experimental development on biotechnology

Registered office

395 King Street
Aberdeen
AB24 5RP
Scotland

Filing status

Accounts
Next due: 2026-07-31
Last made up to: 2024-10-31
Confirmation statement
Next due: 2026-10-24
Last: 2025-10-10

Officers (2 active · 0 resigned)

CORR, Glenn Andrew
director · ~56y · appointed 2024-07-23
View their other companies + combined net worth →
Active
SCHEMBRI-WISCHIK, Marcus
director · ~46y · appointed 2021-10-11
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (13 total)

confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-10-10
change-person-director-company-with-change-date
officers · CH01
2025-07-10
accounts-with-accounts-type-dormant
accounts · AA
2025-07-07
change-person-director-company-with-change-date
officers · CH01
2025-02-24
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-10-20
appoint-person-director-company-with-name-date
officers · AP01
2024-07-23
accounts-with-accounts-type-dormant
accounts · AA
2024-07-23
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-10-24
accounts-with-accounts-type-dormant
accounts · AA
2023-04-03
memorandum-articles
incorporation · MA
2022-11-21
resolution
resolution · RESOLUTIONS
2022-11-21
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-10-21
incorporation-company
incorporation · NEWINC
2021-10-11